Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.5K

Current research on pediatric patients with bronchiolitis obliterans in Brazil

Silvia Onoda Tomikawa1, Joaquim Carlos Rodrigues1

  • 1Pediatric Pulmonology Division, Children's Institute, Clinical Hospital, University of São Paulo, Brazil.

Intractable & Rare Diseases Research
|February 13, 2015
PubMed

Insights

Bronchiolitis obliterans (BO) is a severe pediatric lung disease causing airway obstruction after viral infections. This review highlights its clinical, radiological features, and outcomes, focusing on Brazilian research.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Bronchiolitis obliterans (BO) is a rare, severe condition affecting terminal bronchioles.
  • It often follows severe lung viral infections in children.
  • Characterized by inflammation and fibrosis, leading to persistent airway obstruction.

Purpose of the Study:

  • To review the clinical and radiological characteristics of pediatric BO.
  • To discuss patient outcomes in Bronchiolitis obliterans.
  • To emphasize current research on BO in Brazil.

Main Methods:

  • Literature review of Bronchiolitis obliterans in pediatric patients.
  • Analysis of clinical presentation and diagnostic findings.
  • Examination of treatment approaches and outcomes.

Main Results:

  • Diagnosis relies on history, persistent airway obstruction, and HRCT findings.
  • Supportive care is standard; bronchodilators and corticosteroids are common treatments.
  • Outcomes and treatment efficacy vary, with ongoing research.

Conclusions:

  • Pediatric Bronchiolitis obliterans requires careful clinical and radiological assessment.
  • Further research, particularly in Brazil, is needed to improve treatment and outcomes.
  • Understanding BO's characteristics is crucial for managing this severe pediatric lung disease.

Keywords:
Bronchiolitis obliteranschildrenobstructive pulmonary disease

More Related Videos

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

21.2K
Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield11:47

Bronchoalveolar Lavage BAL for Research; Obtaining Adequate Sample Yield

Published on: March 24, 2014

76.0K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
2
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K